Ratings by H.C. Wainwright (Ed Arce)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/1/2024 | Akebia Therapeutics | AKBA | Maintain | Buy (N/A) |
|
Details | ||
| 3/19/2024 | Acurx Pharmaceuticals inc. | ACXP | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2024 | Mirum Pharamceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2024 | ZyVersa Therapeutics, Inc. | ZVSA | Maintain | Buy (N/A) |
|
Details | ||
| 3/4/2024 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2024 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/23/2024 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 2/22/2024 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2024 | Inventiva SA | IVA | Maintain | Buy (N/A) |
|
Details | ||
| 2/13/2024 | CymaBay Therapeutic | CBAY | Downgrade | Neutral (Buy) |
32.21 (32.48) |
0.84% | Details | |
| 2/7/2024 | Iterum Therapeutics | ITRM | Upgrade | Buy (Neutral) |
1.58 (1.55) |
-1.9% | Details | |
| 2/5/2024 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 1/23/2024 | Talphera | TLPH | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2023 | Inventiva SA | IVA | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2023 | 89bio Inc. | ETNB | Maintain | Buy (N/A) |
|
Details | ||
| 12/19/2023 | Mirum Pharamceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2023 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/18/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 12/15/2023 | Acurx Pharmaceuticals inc. | ACXP | Maintain | Buy (N/A) |
|
Details | ||
| 12/6/2023 | ZyVersa Therapeutics, Inc. | ZVSA | Maintain | Buy (N/A) |
|
Details | ||
| 11/29/2023 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 11/21/2023 | Enanta Pharmaceuticals | ENTA | Maintain | Buy (N/A) |
|
Details | ||
| 11/17/2023 | Akebia Therapeutics | AKBA | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2023 | Durect Corp | DRRX | Downgrade | Neutral (Buy) |
2.58 (0.88) |
-65.89% | Details | |
| 11/3/2023 | Mirum Pharamceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2023 | Ardelyx, Inc | ARDX | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2023 | Enanta Pharmaceuticals | ENTA | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2023 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2023 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/27/2023 | Intercept Pharmaceuticals | ICPT | Downgrade | Neutral (Buy) |
18.71 (19.00) |
1.55% | Details | |
| 9/26/2023 | Vera Therapeutics | VERA | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2023 | AcelRx Pharmaceuticals | ACRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2023 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2023 | ZyVersa Therapeutics, Inc. | ZVSA | New Coverage | Buy (N/A) |
0.12 (0.61) |
408.33% | Details | |
| 9/7/2023 | Ardelyx, Inc | ARDX | New Coverage | Buy (N/A) |
4.73 (6.43) |
35.94% | Details | |
| 8/28/2023 | Akebia Therapeutics | AKBA | Upgrade | Buy (Neutral) |
1.15 (1.37) |
19.13% | Details | |
| 8/18/2023 | AcelRx Pharmaceuticals | ACRX | Upgrade | Buy (Neutral) |
0.84 (0.86) |
2.38% | Details | |
| 8/16/2023 | Unicycive Therapeutics | UNCY | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2023 | Acurx Pharmaceuticals inc. | ACXP | Maintain | Buy (N/A) |
|
Details | ||
| 8/14/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2023 | Durect Corp | DRRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2023 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 8/1/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 7/18/2023 | Mirum Pharamceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 7/13/2023 | Intercept Pharmaceuticals | ICPT | Upgrade | Buy (Sell) |
11.15 (19.00) |
70.4% | Details | |
| 7/5/2023 | Genfit | GNFT | Maintain | Buy (N/A) |
|
Details | ||
| 6/30/2023 | Unicycive Therapeutics | UNCY | Maintain | Buy (N/A) |
|
Details | ||
| 6/7/2023 | Paratek Pharmaceuticals | PRTK | Downgrade | Neutral (Buy) |
2.17 (2.23) |
2.76% | Details | |
| 6/7/2023 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 6/1/2023 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/22/2023 | Intercept Pharmaceuticals | ICPT | Downgrade | Sell (Neutral) |
13.56 (19.00) |
40.12% | Details | |
| 5/16/2023 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 5/12/2023 | Vera Therapeutics | VERA | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2023 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2023 | Arcturus Therapeutics | ARCT | Upgrade | Buy (N/A) |
29.41 (26.98) |
-8.26% | Details | |
| 5/8/2023 | 89bio Inc. | ETNB | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2023 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 5/1/2023 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 4/26/2023 | Akebia Therapeutics | AKBA | Maintain | Neutral (N/A) |
|
Details | ||
| 4/17/2023 | Genfit | GNFT | Maintain | Buy (N/A) |
|
Details | ||
| 3/31/2023 | Inventiva SA | IVA | Maintain | Buy (N/A) |
|
Details | ||
| 3/30/2023 | Vera Therapeutics | VERA | Maintain | Buy (N/A) |
|
Details | ||
| 3/23/2023 | Cidara Therapeutics | CDTX | Maintain | Buy (N/A) |
|
Details | ||
| 3/22/2023 | 89bio Inc. | ETNB | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | 89bio Inc. | ETNB | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | Paratek Pharmaceuticals | PRTK | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 3/20/2023 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 3/8/2023 | Durect Corp | DRRX | Maintain | Buy (N/A) |
|
Details | ||
| 2/21/2023 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 2/15/2023 | Mirum Pharamceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Enanta Pharmaceuticals | ENTA | Maintain | Buy (N/A) |
|
Details | ||
| 1/10/2023 | Albireo Pharma | ALBO | Downgrade | Neutral (Buy) |
43.85 (44.15) |
0.68% | Details | |
| 1/4/2023 | Vera Therapeutics | VERA | Maintain | Buy (N/A) |
|
Details | ||
| 12/30/2022 | Ultragenyx Pharma | RARE | New Coverage | Buy (N/A) |
45.17 (44.28) |
-1.97% | Details | |
| 12/19/2022 | Acurx Pharmaceuticals inc. | ACXP | New Coverage | Buy (N/A) |
3.83 (2.03) |
-47% | Details | |
| 12/15/2022 | Axcella Health Inc. | AXLA | Downgrade | Neutral (Buy) |
0.89 (4.58) |
414.61% | Details | |
| 12/9/2022 | Enanta Pharmaceuticals | ENTA | New Coverage | Buy (N/A) |
41.96 (12.92) |
-69.21% | Details | |
| 12/6/2022 | Durect Corp | DRRX | Maintain | Buy (N/A) |
|
Details | ||
| 11/28/2022 | Unicycive Therapeutics | UNCY | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Neutral (N/A) |
|
Details | ||
| 11/14/2022 | Mirum Pharamceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 11/10/2022 | Arbutus Biopharma | ABUS | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/7/2022 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 11/2/2022 | Axcella Health Inc. | AXLA | Maintain | Buy (N/A) |
|
Details | ||
| 10/14/2022 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2022 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 10/3/2022 | Axcella Health Inc. | AXLA | Maintain | Buy (N/A) |
|
Details | ||
| 9/26/2022 | Inventiva SA | IVA | Maintain | Buy (N/A) |
|
Details | ||
| 9/20/2022 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 8/22/2022 | Vera Therapeutics | VERA | Maintain | Buy (N/A) |
|
Details | ||
| 8/17/2022 | 89bio Inc. | ETNB | Maintain | Buy (Buy) |
|
Details | ||
| 8/16/2022 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2022 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 8/8/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2022 | Travere Therapeutics | TVTX | Maintain | Buy (N/A) |
|
Details | ||
| 7/27/2022 | 89bio Inc. | ETNB | Maintain | Buy (N/A) |
|
Details | ||
| 7/19/2022 | Unicycive Therapeutics | UNCY | Maintain | Buy (Buy) |
|
Details | ||
| 7/11/2022 | Pliant Therapeutics | PLRX | Maintain | Buy (N/A) |
|
Details | ||
| 7/7/2022 | Albireo Pharma | ALBO | Maintain | Buy (Buy) |
|
Details | ||
| 7/1/2022 | Akebia Therapeutics | AKBA | Maintain | Buy (Buy) |
|
Details | ||
| 6/22/2022 | Paratek Pharmaceuticals | PRTK | Maintain | Buy (Buy) |
|
Details | ||
| 6/8/2022 | Unicycive Therapeutics | UNCY | New Coverage | Buy (N/A) |
1.05 (1.04) |
-0.95% | Details | |
| 5/23/2022 | Mirum Pharamceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2022 | Galmed Pharmaceuticals | GLMD | Maintain | Neutral (Neutral) |
|
Details | ||
| 5/17/2022 | Galectin Therapeutics | GALT | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | Travere Therapeutics | TVTX | Maintain | Neutral (N/A) |
|
Details | ||
| 5/4/2022 | Pliant Therapeutics | PLRX | Maintain | Buy (Buy) |
|
Details | ||
| 5/3/2022 | Galmed Pharmaceuticals | GLMD | Downgrade | Neutral (Buy) |
1.22 (0.40) |
-67.21% | Details | |
| 5/2/2022 | Vera Therapeutics | VERA | New Coverage | Buy (N/A) |
20.00 (39.95) |
99.75% | Details | |
| 4/8/2022 | Akebia Therapeutics | AKBA | Maintain | Neutral (Neutral) |
|
Details | ||
| 4/5/2022 | CymaBay Therapeutic | CBAY | Maintain | Buy (Buy) |
|
Details | ||
| 3/31/2022 | Akebia Therapeutics | AKBA | Downgrade | Neutral (Buy) |
0.83 (1.37) |
65.06% | Details | |
| 3/30/2022 | AcelRx Pharmaceuticals | ACRX | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/29/2022 | Albireo Pharma | ALBO | Maintain | Buy (Buy) |
|
Details | ||
| 3/14/2022 | Arbutus Biopharma | ABUS | Maintain | Buy (N/A) |
|
Details | ||
| 3/14/2022 | AcelRx Pharmaceuticals | ACRX | Downgrade | Neutral (Buy) |
0.34 (0.86) |
152.94% | Details | |
| 3/9/2022 | Paratek Pharmaceuticals | PRTK | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2022 | Entasis Therapeutics | ETTX | Downgrade | Neutral (Buy) |
1.74 (2.19) |
25.86% | Details | |
| 3/3/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Neutral (Neutral) |
|
Details | ||
| 3/1/2022 | Arcturus Therapeutics | ARCT | Maintain | Neutral (N/A) |
|
Details | ||
| 3/1/2022 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2022 | Akero Therapeutics | AKRO | Maintain | Buy (Buy) |
|
Details | ||
| 2/28/2022 | Travere Therapeutics | TVTX | New Coverage | Buy (N/A) |
26.85 (5.45) |
-79.7% | Details | |
| 2/23/2022 | Akebia Therapeutics | AKBA | Maintain | Buy (Buy) |
|
Details | ||
| 2/23/2022 | Albireo Pharma | ALBO | Maintain | Buy (Buy) |
|
Details | ||
| 2/18/2022 | Arcturus Therapeutics | ARCT | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/8/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Neutral (Neutral) |
|
Details | ||
| 2/8/2022 | Intercept Pharmaceuticals | ICPT | Maintain | Neutral (Neutral) |
|
Details | ||
| 1/26/2022 | Arcturus Therapeutics | ARCT | Maintain | Neutral (N/A) |
|
Details | ||
| 1/12/2022 | Mirum Pharamceuticals | MIRM | Maintain | Buy (Buy) |
|
Details | ||
| 12/20/2021 | Genfit | GNFT | Upgrade | Buy (Neutral) |
5.09 (3.49) |
-31.43% | Details | |
| 12/20/2021 | 89bio Inc. | ETNB | New Coverage | Buy (N/A) |
11.48 (8.58) |
-25.26% | Details | |
| 12/8/2021 | Arbutus Biopharma | ABUS | Maintain | Buy (N/A) |
|
Details | ||
| 12/3/2021 | Cidara Therapeutics | CDTX | New Coverage | Buy (N/A) |
1.45 (12.29) |
747.59% | Details | |
| 11/23/2021 | Inventiva SA | IVA | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2021 | Dicerna Pharmaceuticals | DRNA | Downgrade | Neutral (Buy) |
21.28 (38.22) |
79.61% | Details | |
| 11/15/2021 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | Paratek Pharmaceuticals | PRTK | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 11/8/2021 | Arbutus Biopharma | ABUS | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2021 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 11/4/2021 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/3/2021 | Pliant Therapeutics | PLRX | New Coverage | Buy (N/A) |
16.81 (11.90) |
-29.21% | Details | |
| 10/22/2021 | Metacrine Inc. | MTCR | Downgrade | Neutral (Buy) |
3.83 (0.49) |
-87.21% | Details | |
| 10/22/2021 | Match Group | MTCH | Downgrade | Neutral (Buy) |
175.53 (31.94) |
-81.8% | Details | |
| 10/19/2021 | Entasis Therapeutics | ETTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/30/2021 | Mirum Pharamceuticals | MIRM | Maintain | Buy (N/A) |
|
Details | ||
| 9/22/2021 | Inventiva SA | IVA | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2021 | Assembly Biosciences | ASMB | New Coverage | Neutral (N/A) |
3.23 (13.48) |
317.34% | Details | |
| 8/16/2021 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2021 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 8/2/2021 | Intercept Pharmaceuticals | ICPT | Maintain | Neutral (N/A) |
|
Details | ||
| 7/26/2021 | Iterum Therapeutics | ITRM | Downgrade | Neutral (Buy) |
1.13 (1.55) |
37.17% | Details | |
| 7/21/2021 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 7/6/2021 | Axcella Health Inc. | AXLA | New Coverage | Buy (N/A) |
3.97 (4.58) |
15.37% | Details | |
| 6/23/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2021 | Paratek Pharmaceuticals | PRTK | Maintain | Buy (N/A) |
|
Details | ||
| 6/14/2021 | Metacrine Inc. | MTCR | New Coverage | Buy (N/A) |
4.14 (3.83) |
-7.49% | Details | |
| 5/24/2021 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 3/17/2021 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 3/15/2021 | Iterum Therapeutics | ITRM | Upgrade | Buy (Neutral) |
1.55 (1.13) |
-27.1% | Details | |
| 3/12/2021 | Intercept Pharmaceuticals | ICPT | Upgrade | Neutral (Sell) |
20.77 (19.00) |
-8.52% | Details | |
| 2/23/2021 | Intercept Pharmaceuticals | ICPT | Downgrade | Sell (Neutral) |
29.86 (20.77) |
-30.44% | Details | |
| 1/25/2021 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 12/29/2020 | Arcturus Therapeutics | ARCT | Downgrade | Neutral (Buy) |
92.42 (26.98) |
-70.81% | Details | |
| 12/18/2020 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 12/17/2020 | Arbutus Biopharma | ABUS | New Coverage | Buy (N/A) |
4.41 (2.75) |
-37.64% | Details | |
| 11/10/2020 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 10/26/2020 | Akebia Therapeutics | AKBA | Maintain | Buy (N/A) |
|
Details | ||
| 9/8/2020 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 8/19/2020 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2020 | Galectin Therapeutics | GALT | Maintain | Buy (N/A) |
|
Details | ||
| 8/11/2020 | Paratek Pharmaceuticals | PRTK | Maintain | Buy (N/A) |
|
Details | ||
| 8/4/2020 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 8/3/2020 | Mirum Pharamceuticals | MIRM | New Coverage | Buy (N/A) |
22.08 (24.02) |
8.79% | Details | |
| 7/27/2020 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 7/23/2020 | Genfit | GNFT | Maintain | Neutral (N/A) |
|
Details | ||
| 7/22/2020 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 7/20/2020 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 7/16/2020 | Albireo Pharma | ALBO | Maintain | Buy (N/A) |
|
Details | ||
| 7/1/2020 | Akero Therapeutics | AKRO | Maintain | Buy (N/A) |
|
Details | ||
| 6/29/2020 | Intercept Pharmaceuticals | ICPT | Maintain | Neutral (N/A) |
|
Details | ||
| 6/25/2020 | Intercept Pharmaceuticals | ICPT | New Coverage | Neutral (N/A) |
78.16 (19.00) |
-75.69% | Details | |
| 6/16/2020 | Iterum Therapeutics | ITRM | Downgrade | Neutral (Buy) |
1.54 (1.55) |
0.65% | Details | |
| 5/27/2020 | Durect Corp | DRRX | Maintain | Buy (N/A) |
|
Details | ||
| 5/26/2020 | CymaBay Therapeutic | CBAY | Upgrade | Buy (Neutral) |
3.86 (32.48) |
741.45% | Details | |
| 4/14/2020 | Entasis Therapeutics | ETTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2020 | Arcturus Therapeutics | ARCT | Maintain | Buy (N/A) |
|
Details | ||
| 4/8/2020 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 3/2/2020 | Akero Therapeutics | AKRO | New Coverage | Buy (N/A) |
21.77 (20.26) |
-6.94% | Details | |
| 2/7/2020 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 1/8/2020 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 1/3/2020 | Durect Corp | DRRX | Maintain | Buy (N/A) |
|
Details | ||
| 12/16/2019 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 11/26/2019 | CymaBay Therapeutic | CBAY | Downgrade | Neutral (Buy) |
1.33 (3.86) |
190.23% | Details | |
| 11/19/2019 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 11/18/2019 | Akebia Therapeutics | AKBA | Maintain | Buy (N/A) |
|
Details | ||
| 11/14/2019 | Paratek Pharmaceuticals | PRTK | Maintain | Buy (N/A) |
|
Details | ||
| 10/31/2019 | Genfit | GNFT | Maintain | Buy (N/A) |
|
Details | ||
| 9/3/2019 | Tetraphase Pharmaceuticals | TTPH | Downgrade | Neutral (Buy) |
0.26 (2.20) |
746.15% | Details | |
| 8/19/2019 | Entasis Therapeutics | ETTX | New Coverage | Buy (N/A) |
8.25 (2.19) |
-73.45% | Details | |
| 8/12/2019 | Melinta Therapeutics Inc. | MLNT | Downgrade | Neutral (Buy) |
2.85 (0.50) |
-82.46% | Details | |
| 8/8/2019 | Organovo Holdings | ONVO | Downgrade | Neutral (Buy) |
0.28 (1.00) |
257.14% | Details | |
| 8/6/2019 | Akebia Therapeutics | AKBA | Maintain | Buy (N/A) |
|
Details | ||
| 7/11/2019 | Akebia Therapeutics | AKBA | Maintain | Buy (N/A) |
|
Details | ||
| 6/21/2019 | Iterum Therapeutics | ITRM | New Coverage | Buy (N/A) |
6.48 (1.54) |
-76.23% | Details | |
| 6/12/2019 | CymaBay Therapeutic | CBAY | Maintain | Buy (N/A) |
|
Details | ||
| 5/23/2019 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 5/3/2019 | Collegium Pharmaceutical | COLL | New Coverage | Buy (N/A) |
13.82 (35.48) |
156.73% | Details | |
| 4/23/2019 | Genfit | GNFT | Maintain | Buy (N/A) |
|
Details | ||
| 4/5/2019 | Arcturus Therapeutics | ARCT | New Coverage | Buy (N/A) |
8.34 (26.98) |
223.5% | Details | |
| 4/3/2019 | Akebia Therapeutics | AKBA | Maintain | Neutral (N/A) |
|
Details | ||
| 3/22/2019 | Conatus Pharmaceuticals | CNAT | Downgrade | Neutral (Buy) |
2.88 (0.56) |
-80.56% | Details | |
| 3/20/2019 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details | ||
| 3/12/2019 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (Buy) |
|
Details | ||
| 3/4/2019 | Collegium Pharmaceutical | COLL | Maintain | Buy (N/A) |
|
Details | ||
| 2/28/2019 | Albireo Pharma | ALBO | New Coverage | Buy (N/A) |
26.77 (44.15) |
64.92% | Details | |
| 2/21/2019 | Achaogen | AKAO | Maintain | Neutral (N/A) |
|
Details | ||
| 12/13/2018 | Organovo Holdings | ONVO | New Coverage | Buy (N/A) |
1.03 (0.28) |
-72.82% | Details | |
| 12/6/2018 | Conatus Pharmaceuticals | CNAT | Maintain | Buy (N/A) |
|
Details | ||
| 11/23/2018 | Paratek Pharmaceuticals | PRTK | Maintain | Buy (N/A) |
|
Details | ||
| 11/12/2018 | Achaogen | AKAO | Downgrade | Neutral (Buy) |
2.65 (0.11) |
-95.85% | Details | |
| 11/5/2018 | Trevena | TRVN | Downgrade | Neutral (Buy) |
1.05 (1.19) |
13.33% | Details | |
| 10/22/2018 | Melinta Therapeutics Inc. | MLNT | Maintain | Buy (N/A) |
|
Details | ||
| 10/15/2018 | AcelRx Pharmaceuticals | ACRX | Maintain | Buy (N/A) |
|
Details | ||
| 10/12/2018 | Trevena | TRVN | Maintain | Buy (N/A) |
|
Details | ||
| 10/10/2018 | AcelRx Pharmaceuticals | ACRX | Maintain | Buy (N/A) |
|
Details | ||
| 9/13/2018 | Dicerna Pharmaceuticals | DRNA | Maintain | Buy (N/A) |
|
Details | ||
| 9/11/2018 | Melinta Therapeutics Inc. | MLNT | New Coverage | Buy (N/A) |
4.30 (2.85) |
-33.72% | Details | |
| 8/28/2018 | Tetraphase Pharmaceuticals | TTPH | Maintain | Buy (N/A) |
|
Details | ||
| 8/15/2018 | Dicerna Pharmaceuticals | DRNA | Upgrade | Buy (Neutral) |
14.76 (21.28) |
44.17% | Details | |
| 8/14/2018 | Spero Therapeutics | SPRO | Maintain | Buy (N/A) |
|
Details | ||
| 8/13/2018 | Aurinia Pharmaceuticals | AUPH | Maintain | Buy (N/A) |
|
Details |
